EssilorLuxottica Logo

EssilorLuxottica

EL | PA

Overview

Corporate Details

ISIN(s):
FR0000121667 (+22 more)
LEI:
549300M3VH1A3ER1TB49
Country:
France
Address:
147 RUE DE PARIS, 94220 CHARENTON-LE-PONT
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

EssilorLuxottica is a global leader in the design, manufacture, and distribution of ophthalmic lenses, frames, and sunglasses. Formed in 2018 through the merger of Essilor and Luxottica, the company operates a vertically integrated business model covering product development, manufacturing, and a worldwide retail network. Its portfolio features iconic proprietary and licensed eyewear brands, including Ray-Ban, Oakley, and Persol, alongside advanced lens technologies such as Varilux and Transitions. The company also provides vision care instruments and equipment for eye care professionals and develops med-tech and smart eyewear solutions to fulfill its mission of helping people 'see more and be more'.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for EssilorLuxottica. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-20 15:00
M&A Activity
EssilorLuxottica et Meta lancent Oakley Meta, créant ainsi la nouvelle catégor…
French 184.4 KB
2025-06-20 15:00
Regulatory News Service
EssilorLuxottica and Meta to launch Oakley Meta, creating a new category of Per…
English 200.3 KB
2025-06-17 16:28
Major Shareholding Notification
Franchissement de seuils
French 97.5 KB
2025-06-12 18:00
Declaration of Voting Results & Voting Rights Announcements
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capi…
French 151.0 KB
2025-06-12 18:00
Declaration of Voting Results & Voting Rights Announcements
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as …
English 110.0 KB
2025-06-05 08:00
M&A Activity
EssilorLuxottica signs an agreement to acquire A-Look, Seen and OWL retail stor…
English 134.4 KB
2025-06-03 20:30
Capital/Financing Update
EssilorLuxottica : Succès du placement d'une émission obligataire d’un montant …
French 162.4 KB
2025-06-03 20:30
Capital/Financing Update
EssilorLuxottica: successful Euro 1 billion bond issuance
English 170.0 KB
2025-06-03 16:30
Notice of Dividend Amount
EssilorLuxottica: Résultat du paiement du dividende en actions et constatation …
French 105.1 KB
2025-06-03 16:30
Notice of Dividend Amount
EssilorLuxottica: Result of the payment of dividends in shares and record of th…
English 113.4 KB
2025-05-30 08:00
M&A Activity
EssilorLuxottica to acquire Optegra clinics, another leap forward in its med-te…
English 155.6 KB
2025-05-30 08:00
M&A Activity
EssilorLuxottica va acquérir les cliniques Optegra, une nouvelle étape clé dans…
French 154.9 KB
2025-05-20 18:00
Declaration of Voting Results & Voting Rights Announcements
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as …
English 110.0 KB
2025-05-20 18:00
Declaration of Voting Results & Voting Rights Announcements
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capi…
French 150.5 KB
2025-05-06 18:00
Transaction in Own Shares
EssilorLuxottica: Disclosure of transactions in own shares
English 119.6 KB

Automate Your Workflow. Get a real-time feed of all EssilorLuxottica filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for EssilorLuxottica via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-07-31 N/A Other Buy 1,000 214,020.60 EUR
2024-07-29 N/A Other Buy 1,200 250,797.60 EUR
2023-12-20 N/A Other Buy 1,414 195,047.16 EUR
2023-12-20 N/A Other Buy 139 19,173.66 EUR
2023-12-20 N/A Other Buy 109 15,035.46 EUR
2023-12-20 N/A Other Buy 106 14,621.64 EUR
2023-10-27 N/A Other Buy 3,000 504,038.40 EUR
2023-10-02 N/A Other Sell 35,000 5,835,900.00 EUR
2023-10-02 N/A Other Buy 35,000 5,835,900.00 EUR
2023-10-02 N/A Other Buy 35,000 N/A

Peer Companies

Company Country Ticker View
Theradiag Logo
Develops IVD tests for biotherapy monitoring in autoimmune diseases and oncology.
France ALTER
TISSUE REGENIX GROUP PLC Logo
Develops regenerative biological products for orthopaedic and dental markets.
United Kingdom TRX
Developing disruptive spinal fixation devices for the vertebral surgery market.
United Kingdom N/A
Ulisse Biomed Logo
Provides a portable platform for rapid point-of-need genetic analysis and diagnostics.
Italy UBM
Viromed Medical Logo
Develops cold plasma tech for infection control, wound care, and air disinfection for healthcare.
Germany VMED
Vitrolife Logo
Global provider of medical devices and genetic testing services for the IVF treatment journey.
Sweden VITR
Xvivo Perfusion Logo
Develops ex-vivo machine perfusion systems to improve organ viability for transplantation.
Sweden XVIVO
Ypsomed Holding AG Logo
Develops injection systems for self-medication, partnering with pharma and biotech firms.
Switzerland YPSN